Literature DB >> 10725211

Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.

J McDermott1, S Karanjia, Z Love, E Barklis.   

Abstract

To analyze contacts made by Moloney murine leukemia virus (M-MuLV) capsid (CA) proteins in immature and mature virus particles, we have employed a cysteine-specific crosslinking approach that permits the identification of retroviral Gag protein interactions at particular residues. For analysis, single cysteine creation mutations were made in the context of protease-deficient or protease-competent parental constructs. Cysteine creation mutations were chosen near the N- and C-termini of CA and at a site adjacent to the M-MuLV Glu-Ala Fv1 N/B host range determination sequence. Analysis of immature virions showed that PrGag proteins were crosslinked at C-terminal CA residues to form dimers while crosslinking of particle-associated N-terminal and N/B region mutant proteins did not yield dimers, but showed evidence of linking to an unknown 140- to 160-kDa partner. Analysis of mature virions demonstrated that both N- and C-terminal CA residues participated in dimer formation, suggesting that processed CA N- and C-termini are free to establish interprotein associations. Interestingly, N/B region mutant residues in mature virus particles did not crosslink to form dimers, but showed a novel crosslinked band, consistent with an interaction between the N/B tropism determining region and a cellular protein of 45-55 kDa. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725211     DOI: 10.1006/viro.2000.0212

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Hantavirus nucleocapsid protein oligomerization.

Authors:  A Alfadhli; Z Love; B Arvidson; J Seeds; J Willey; E Barklis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

3.  Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain.

Authors:  Isabel Scholz; Brian Arvidson; Doug Huseby; Eric Barklis
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly.

Authors:  Ayna Alfadhli; Tenzin Choesang Dhenub; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Analysis of the N-terminal region of the murine leukemia virus nucleocapsid protein.

Authors:  Amelia Still; Douglas Huseby; Eric Barklis
Journal:  Virus Res       Date:  2010-10-08       Impact factor: 3.303

6.  The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.

Authors:  E Bacharach; J Gonsky; K Alin; M Orlova; S P Goff
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination.

Authors:  Sara Rasmussen Cheslock; Dexter T K Poon; William Fu; Terence D Rhodes; Louis E Henderson; Kunio Nagashima; Connor F McGrath; Wei-Shau Hu
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Capsid-specific nanobody effects on HIV-1 assembly and infectivity.

Authors:  Ayna Alfadhli; CeAnn Romanaggi; Robin Lid Barklis; Ilaria Merutka; Timothy A Bates; Fikadu G Tafesse; Eric Barklis
Journal:  Virology       Date:  2021-07-05       Impact factor: 3.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.